|
Volumn 11, Issue 4, 2003, Pages 458-461
|
Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
AMANTADINE;
AMITRIPTYLINE;
AMPICILLIN;
ATROPINE;
AZATHIOPRINE;
CAPTOPRIL;
CEFAMANDOLE;
CEFOXITIN;
CHLORDIAZEPOXIDE;
CHLORTALIDONE;
CHOLINESTERASE INHIBITOR;
CIMETIDINE;
CLINDAMYCIN;
CLORAZEPATE;
CODEINE;
CORTICOSTERONE;
CYCLOSERINE;
CYCLOSPORIN;
DESIPRAMINE;
DEXAMETHASONE;
DIAZEPAM;
DIGOXIN;
DILTIAZEM;
DIPHENHYDRAMINE;
DIPYRIDAMOLE;
DONEPEZIL;
FLUNITRAZEPAM;
HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE;
UNINDEXED DRUG;
ALZHEIMER DISEASE;
ANTICHOLINERGIC EFFECT;
ARTICLE;
COGNITIVE DEFECT;
CONFUSION;
DELIRIUM;
DISEASE COURSE;
DRUG EFFECT;
FEMALE;
HALLUCINATION;
HUMAN;
LONG TERM CARE;
LONG TERM EXPOSURE;
MAJOR CLINICAL STUDY;
MALE;
MINI MENTAL STATE EXAMINATION;
NEUROPSYCHOLOGY;
SEDATION;
SIDE EFFECT;
|
EID: 0038679745
PISSN: 10647481
EISSN: None
Source Type: Journal
DOI: 10.1097/00019442-200307000-00009 Document Type: Article |
Times cited : (106)
|
References (9)
|